Empowering the inventor--the case of monoclonal antibodies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16151388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Academic ownership of intellectual property facilitated wide dissemination and commercialization of antibody technology. Moves at the University of Cambridge to reclaim institutional IP rights should thus be treated with caution.
Medical subject headings
- Antibodies, Monoclonal